Clinical Trial Update: Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating colchicine to prevent post-pericardiotomy syndrome and atrial fibrillation; the study was terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Post-pericardiotomy Syndrome

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation, Post-pericardiotomy Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2017-06-21